Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

The "seagull cry": An initial sign in a child with intracranial carotid stenosis.

Gerstl L, Heinen F, Schroeder AS, Tacke M, Olivieri M, Dorn F, Voll C, Borggraefe I.

Neurology. 2016 Aug 23;87(8):850-1. doi: 10.1212/WNL.0000000000003012. No abstract available.

PMID:
27550894
2.

An Acute Encephalopathy Accelerated by a Large Amount of Milk Consumption.

Moien-Afshari F, Mirhosseini NZ, Lemire EG, Voll CL.

Can J Neurol Sci. 2016 Mar;43(2):345-6. doi: 10.1017/cjn.2015.297. Epub 2015 Nov 9. No abstract available.

PMID:
26549653
3.

Apolar bimesogens and the incidence of the twist-bend nematic phase.

Mandle RJ, Davis EJ, Archbold CT, Voll CC, Andrews JL, Cowling SJ, Goodby JW.

Chemistry. 2015 May 26;21(22):8158-67. doi: 10.1002/chem.201500423. Epub 2015 Apr 20.

PMID:
25900846
4.

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.

Bousser MG, Amarenco P, Chamorro A, Fisher M, Ford I, Fox KM, Hennerici MG, Mattle HP, Rothwell PM, de Cordoüe A, Fratacci MD; PERFORM Study Investigators.

Lancet. 2011 Jun 11;377(9782):2013-22. doi: 10.1016/S0140-6736(11)60600-4. Epub 2011 May 25. Erratum in: Lancet. 2011 Jul 30;378(9789):402.

PMID:
21616527
5.

Neuroimaging and neurophysiology studies in carriers of cree leukoencephalopathy.

Huntsman RJ, Lemire EG, Voll CL, Wiebe S, Lowry NJ.

Can J Neurol Sci. 2011 Mar;38(2):347-8. No abstract available.

PMID:
21320845
6.

Hirayama disease.

Tynan J, Frangou E, Voll C, Otani R, Harder S.

Can J Neurol Sci. 2010 Sep;37(5):703-5. No abstract available.

PMID:
21059525
7.

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.

Aurora SK, Dodick DW, Turkel CC, DeGryse RE, Silberstein SD, Lipton RB, Diener HC, Brin MF; PREEMPT 1 Chronic Migraine Study Group.

Cephalalgia. 2010 Jul;30(7):793-803. doi: 10.1177/0333102410364676. Epub 2010 Mar 17.

PMID:
20647170
8.

Utility of transcranial doppler in idiopathic intracranial hypertension.

Hunter G, Voll C, Rajput M.

Can J Neurol Sci. 2010 Mar;37(2):235-9.

PMID:
20437935
9.

A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke: modified Randomized Exposure Controlled Trial (mRECT).

Teal P, Davis S, Hacke W, Kaste M, Lyden PD; Modified Randomized Exposure Controlled Trial Study Investigators, Fierus M; Bayer HealthCare AG.

Stroke. 2009 Nov;40(11):3518-25. doi: 10.1161/STROKEAHA.109.551382. Epub 2009 Sep 10.

10.

Autoimmune inflammatory myopathy after treatment with ipilimumab.

Hunter G, Voll C, Robinson CA.

Can J Neurol Sci. 2009 Jul;36(4):518-20. No abstract available.

PMID:
19650371
11.
12.

Partial anterior cervical cord infarction following vertebral artery dissection.

Machnowska M, Moien-Afshari F, Voll C, Wiebe S.

Can J Neurol Sci. 2008 Nov;35(5):674-7. No abstract available.

PMID:
19235459
13.

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.

Diener HC, Sacco RL, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voigt T, Weber M, Yoon BW; Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group.

Lancet Neurol. 2008 Oct;7(10):875-84. doi: 10.1016/S1474-4422(08)70198-4. Epub 2008 Aug 29. Erratum in: Lancet Neurol. 2008 Nov;7(11):985.

14.

Telmisartan to prevent recurrent stroke and cardiovascular events.

Yusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voigt T, Weber M, Yoon BW; PRoFESS Study Group.

N Engl J Med. 2008 Sep 18;359(12):1225-37. doi: 10.1056/NEJMoa0804593. Epub 2008 Aug 27.

15.

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.

Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, Vandermaelen C, Voigt T, Weber M, Yoon BW; PRoFESS Study Group.

N Engl J Med. 2008 Sep 18;359(12):1238-51. doi: 10.1056/NEJMoa0805002. Epub 2008 Aug 27.

16.

The cardiac R-R variation and sympathetic skin response in the intensive care unit.

Bolton C, Thompson J, Bernardi L, Voll C, Young B.

Can J Neurol Sci. 2007 Aug;34(3):313-5.

PMID:
17803028
17.

Athletic training education programs: to rank or not to rank?

Voll CA, Goodwin JE, Pitney WA.

J Athl Train. 1999 Jan;34(1):48-52.

18.

Neurological complications of infliximab.

Jarand J, Zochodne DW, Martin LO, Voll C.

J Rheumatol. 2006 May;33(5):1018-20. Epub 2006 Mar 1.

PMID:
16511935
19.
20.

First case of variant Creutzfeldt-Jakob disease in Canada.

Jansen GH, Voll CL, Robinson CA, Gervais R, Sutcliffe T, Bergeron C, Coulthart MB, Giulivi A.

Can Commun Dis Rep. 2003 Jul 1;29(13):117-20. English, French. No abstract available. Erratum in: Can Commun Dis Rep. 2003 Aug 1;29(15):136.

Supplemental Content

Loading ...
Support Center